Interestingly, Rab25 downregulation was found to impair EGFR signalling, with a consequent reduction in ERK and AKT phosphorylation in radioresistant lung adenocarcinoma and nasopharyngeal carcinoma cells [25]. Here, RAB25 is linked to nasopharyngeal carcinoma.